Heidelberg Pharma
Company providing pre-clinical drug discovery and development services.
Enterprise value
$80—120m
Company register number
HRB 728735 (Mannheim)
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | €80.0m | Post IPO Equity | |
| Total Funding | 000k | ||
WILEX(exited)
dievini Hopp Biotech holding(exited)
Earlybird Venture Capital(exited)
Polar Capital(exited)
Invus(exited)
DH-LT-Investments(exited)
Huadong Medicine(exited)
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (25 %) | (33 %) | 100 % | 100 % | 25 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (200 %) | (500 %) | (250 %) | (125 %) | (200 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 200 % | 450 % | 250 % | 125 % | 200 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Heidelberg Pharma
Edit
ACQUISITION by Eli Lilly Jun 2023